AdaptVac ApS

CVRCVR number38732730

Core data

Name	AdaptVac ApS
Address	Nordre Fasanvej 215, 2000, Frederiksberg
Founded	Jun 22, 2017
Employees (CVR)	8
Locations (P-units)	1 View locations
Website	https://www.adaptvac.com/
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Name	AdaptVac ApS
Address	Nordre Fasanvej 215, 2000, Frederiksberg
Founded	Jun 22, 2017
Employees (CVR)	8

Locations (P-units)	1 View locations
Website	https://www.adaptvac.com/
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of AdaptVac ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.

Free account

Description

AdaptVac is a clinical-stage biotechnology company developing a new class of vaccines that deliver broad, durable and adaptable protection. Founded in 2017, it is based on a capsid Virus-like Particle (cVLP) platform technology invented at the University of Copenhagen and focuses on therapeutic and prophylactic vaccines for oncology, infectious diseases, and immunological disorders.

AdaptVac develops therapeutic and prophylactic vaccines using its proprietary capsid Virus-like Particle platform, including the MoonCatcher/Tag display platform based on AP205 capsid protein. The platform is used for vaccine development in oncology, infectious diseases, immunological disorders, and equitable access vaccine programs.

Company's own description on virk.dk

Description of key activities of the companyLike previous years, the activities comprise research and development of biotechnology. For more information, see the company´s website www.adaptvac.com

Products & services

Therapeutic vaccines · Prophylactic vaccines · Capsid Virus-like Particle (cVLP) platform technology · MoonCatcher/Tag iso-peptide display platform · ABNCoV2 COVID-19 vaccine program

Industries

Biotechnology · Vaccine development · Biopharmaceuticals

Financials

View detailed financials

Company financials

Reporting period	2025DKK	2024Locked	2023Locked	2022Locked	2021Locked	2020Locked	2019Locked	2018Locked	22 Jun - 31 Dec 2017Locked193 days / short period
Gross profit	-3,160,505	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Operating profit	-9,146,649	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Profit before tax	-9,036,956	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Net income	-7,053,665	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Total assets	22,975,523	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Equity	10,808,696	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Avg. employees	7	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
2017–2025 Unlock financial history

Datapublica Risk Score

Locked

Assesses the risk of financial distress using the company’s accounts, history, and connections.

Company score

0 · Low100 · High

What goes into the assessment

Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details

Standard: Score and risk bandPro: Also a detailed explanation of the factors

See plans Learn about Risk Score

Contact

From cvr.dk

Contact	Phone	Email
Company	2639****Show full	w**@adaptvac.comShow full

From adaptvac.com

Contact	Phone	Email
Main	—	in**@adaptvac.comShow full
GET IN TOUCH	+45 2639****Show full	—

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Person	Roles	Titles
Adam Frederik Sander Bertelsen	Roles BoardManagement	TitlesBESTYRELSESMEDLEM • DIREKTØR
Ali El-Salanti	Roles Board	TitlesBESTYRELSESMEDLEM
Jacob Hjulmand	Roles Board	TitlesBESTYRELSESMEDLEM
Martin Roland Jensen	Roles Board	TitlesBESTYRELSESMEDLEM
Morten Agertoug Nielsen	Roles Board	TitlesFORMAND
Willem Adriaan De Jongh	Roles Management	TitlesADM. DIR.

Auditor

Audit firm	Auditor	Role	From
PKF Munkebo Eriksen Funch, Statsautoriseret Revisions aktie selskab	AuditorThomas Funch	RoleStatsautoriseret revisor	FromJun 12, 2026

Legal owners

View ownership diagram

Owner	Ownership	Voting rights	From
NextGen Vaccines Holding ApS	Ownership50–66.66 %	Voting rights50 %	FromJun 21, 2017
EXPRES2ION BIOTECHNOLOGIES ApS	Ownership33.33–49.99 %	Voting rights33.33 %	FromFeb 1, 2021

Ultimate owners